LABP
Landos Biopharma, Inc. Common Stock
LABP
LABP
Delisted
LABP was delisted on the 23rd of May, 2024.
10 hedge funds and large institutions have $5.58M invested in Landos Biopharma, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 2 closing their positions.
Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.15%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Renaissance Technologies
New York
|
$41K |
| 2 |
CPG
2
Cornerstone Planning Group
Fairfield,
New Jersey
|
$44 |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$154 |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$37 |
Top Sellers
| 1 |
1
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$0 |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $5.44M | 1,486,991 | – | – |
|
2
Macquarie Group
Sydney, NSW 2000,
Australia
| $54K | 14,718 | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $46.1K | 12,604 | – | – |
|
|
4
Renaissance Technologies
New York
| $41K | 11,260 | +1,000 | +10% |
|
5
JPMorgan Chase & Co
New York
| $216 | 59 | – | – |
|
6
BlackRock
New York
| $154 | 42 | – | – |
|
|
7
UBS Group
Zurich,
Switzerland
| $154 | 42 | +5 | +14% |
|
|
CPG
8
Cornerstone Planning Group
Fairfield,
New Jersey
| $44 | 12 | +12 | New |
|
|
9
Wells Fargo
San Francisco,
California
| $37 | 10 | +1 | +11% |
|
|
10
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -1,209 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | – | -1,180 | Closed |
|
12
Acadian Asset Management
Boston,
Massachusetts
| $0 | 134 | – | – |
|
|
CFGS
13
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|